Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	239.26M
Revenue (ttm)	336.02M
Net Income (ttm)	6.37M
Shares Out	81.38M
EPS (ttm)	n/a
PE Ratio	37.59
Forward PE	16.33
Dividend	0.05 (1.64%)
Ex-Dividend Date	May 15, 2025

Volume	10,421
Average Volume	18,431
Open	2.950
Previous Close	2.980
Day's Range	2.930 - 2.980
52-Week Range	2.460 - 3.400
Beta	0.79
RSI	42.66
Earnings Date	Jul 25, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,437
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.